Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, discuss driving forces for the development of hepatocellular carcinoma, including different types of viral hepatitis and non-alcoholic steatohepatitis.
PROs Underscore Utility of Mirvetuximab Soravtansine in FRα+ Ovarian Cancer
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
Personalized Dosimetry With Y-90 Glass Microspheres Shows Positive Activity in HCC
FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm
McCann on the Intersection of Mentorship, Multidisciplinary Care, and Career Aspirations as a Woman in Oncology
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma